CMS Declines To Address Charge Compression For Another Year

CMS finalizes its decision to postpone plans to base its payment calculations on data that separates hospital charges for implantable devices from those for lower-priced medical supplies.

Implantable device makers will have to go at least one more year without seeing the potential positive reimbursement impacts of a Medicare hospital inpatient payment system without the broadly maligned phenomenon of “charge compression.”

Last week, CMS finalized its decision to postpone plans to base its payment calculations on data that separates hospital charges...

More from Policy & Regulation

More from Medtech Insight

Thena Capital’s New Fund Up And Running With £1M Investment In Plexāā’s Breast Cancer Device

 

Thena Capital, the first UK-based early-stage specialist medtech firm, has made its first investment since closing its £50m fund. Medtech Insight spoke with general partner Pamela Walker Geddes to gain insight into Thena Capital’s investment strategy.

Execs On The Move: June 23–27, 2025

 
• By 

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

Court Orders US FDA To Return Trial Diversity Action Plan Guidance To Website

 
• By 

HHS and its agencies violated the law by swiftly implementing “sweeping and poorly thought-through directives that ordered the bulk removal of healthcare resources,” including FDA draft guidances on diversity action plans and sex differences in clinical trials, a federal court said.